← Back
$TNGX All transactions

Tango Therapeutics, Inc.

▼ SELL

$ Value

$125K

Shares

10,204

Price

$12

Filed

Feb 4

Insider

Name

Beckman Daniella

Title

Chief Financial Officer

CIK

0001513422

Roles

Officer

Transaction Details

Transaction Date

2026-02-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

184,410

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. | The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. | Represents the weighted average sales price per share. The shares sold at prices ranging from $11.88 to $12.875 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | Represents the weighted average sales price per share. The shares sold at prices ranging from $12.88 to $12.91 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. | This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0001193125-26-038072

Form Type

4

Issuer CIK

0001819133

Beckman Daniella's History

Date Ticker Type Value
2026-02-03 TNGX $125K
2026-02-03 TNGX $1K
2026-02-02 TNGX A $0
2026-02-02 TNGX A $0
2025-07-17 BPMC D
2025-07-17 BPMC U
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$1K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15